Good news | The new address of Qihengxing R&D is now open!

In January 2022, the R&D laboratory of Beijing Qihengxing Biotechnology Co., Ltd. was officially settled in the "Zhongguancun Life Science Park International Precision Medicine Acceleration Center". The standardized PCR laboratory, open laboratory, fully equipped instruments and equipment, and modern office environment will accelerate the progress of Qihengxing Biological's R&D and better develop top-quality products.

Seek truth from facts

In recent years, genetic engineering technology has swept the molecular biology industry, and genetically engineered enzymes have become the darling of capital. Based on Qihengxing's understanding of enzyme engineering, gene mutation or gene recombination has a "certain" effect on the "specific" performance improvement of enzymes, but only the perfect combination of "enzyme + buffer system" can exert excellent performance. At present, the performance of similar products on the market varies greatly, and a large proportion is caused by buffer.

Qihengxing practices the spirit of seeking truth from facts. In the development of PCR/qPCR systems, it fully respects the natural biological activity of enzymes, deeply studies and understands the mechanism of action of enzymes and the dynamic process of system reactions. Through the study of reaction systems, it develops products suitable for different application needs according to different application scenarios. It protects and utilizes enzymes to the maximum extent and improves the performance of the reaction system. The company has gradually accumulated and refined the working guidelines for the development of "reaction systems".

By learning from one thing, we can understand ten things and apply them to other similar situations. Qihengxing always maintains an attitude of knowledge and respect in the development of products such as nucleic acid extraction, second-generation sequencing, and RNA reference products, and actively researches and optimizes products that meet customer needs.

New starting point, new journey

Qiming East, Hengjiu Future! Qihengxing never forgets its original intention and forges ahead, devoting itself to providing higher quality products and solutions for multiple application scenarios for the biological industry.

We welcome people of insight and like-minded people to join Qihengxing and move towards the future together!

Company Introduction

Since its establishment in 2018, Beijing Qihengxing Biotechnology Co., Ltd. has always put product research and development and quality assurance first. The R&D team has more than 90% masters and doctors, and has more than 10 years of experience in after-sales support of molecular biology products. The scientifically constructed R&D platform and pragmatic product R&D experience are the guarantee for the company to continuously provide customers with high-quality products.

Qihengxing Bio has established six major R&D technology platforms to provide comprehensive product solutions for different customers:

1. qPCR/PCR system platform:

PCR system: realizes inhibitor-resistant PCR amplification and direct PCR amplification of blood/blood card; the multiplex amplification system can realize simultaneous amplification of up to 40 primers;

qPCR system: including SYBR GREEN and probe method, the products have been recognized by customers in low copy gene detection, SNP genotyping, high GC/AT samples, inhibitor resistance, and multiple target amplification;

2. Enzyme Engineering Platform:

A method for evaluating enzyme performance and function has been developed and a national invention patent has been applied for; the developed related enzymes have been applied to the company's product series.

3. Nucleic acid extraction platform:

Development of nucleic acid extraction reagents based on magnetic beads, adapted to automated processes, covering whole blood, plasma, FFPE and other samples.

4. RNA Reference Platform:

The armored RNA design, expression and purification platform provides companies with reference raw materials for RNA testing.

5. NGS Platform:

Develop products such as library sample fragment screening, library concentration determination, ribosomal RNA removal, and DNA/RNA co-construction library based on NGS high-throughput sequencing.

6. Kit customization platform:

We have developed customized projects for many companies (IVD, cell therapy, animal disease), and our products include kits for nucleic acid extraction, disease detection, and quantitative detection of trace nucleic acid residues.

Five-star system, five-star enzyme!